PATENT CLAIM ANALYSIS

Application Number: 15911832
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["514", "171000"]

Abstract:
The invention relates to doxepin, pharmaceutically acceptable salts and prodrugs of doxepin; compositions containing the same, and the use of any of the aforementioned for the treatment of sleep disorders.

Claim (Index 21):
The composition of  claim 15 , wherein the composition is in a form suitable for oral or nasal administration.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 90.0
- Lexical Diversity: 1.36
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14045645', '15357171', '15289288', '13692715', '15797195']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.788022771835726
- 35 USC 102 Novelty (BERT): 0.5790002651503571
- Combined Prediction Score: 0.7671205211671891
- Mean Citation Score: 373.914892
- Max Citation Score: 439.11426
- Similarity Product: 224.21800992145305

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test